Monoclonal Gammopathy of Undetermined Significance (MGUS).

Present in ~5% of all people age 50+

Therefore something all clinicians should know about. Brief summary.

#medtwitter ESH (Haematology)

1/

May 2024 ASN Kidney News kidneynews.org/view/journals/…
Predicting Cisplatin-Induced Kidney Injury Prakash Gudsoorkar American Society of Nephrology

Way to go. Priyanka Gudsoorkar
Trailblazer
#oralhealth
#globalhealth

UC College of Medicine
University of Cincinnati

Onco-Hypertension in Patients with Kidney Disease | American Journal of Nephrology Susana Hong ⁦Northwell Department of Medicine⁩ ⁦American J Nephrol⁩ karger.com/ajn/article/do…

Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology | Cardiorenal Medicine ⁦Rose Mary Attieh⁩ ⁦International Cardio-Oncology Society⁩ ⁦American Society of Onconephrology⁩ karger.com/crm/article/do…

Woot woot! My latest article for ASN Kidney News made the top of American Society of Nephrology’s daily email briefing! Full article here: kidneynews.org/view/journals/…

T0c: C3G is subclassified in: C3GN and DDD.

Both share many overlapping features making it a diagnostic challenge.

Check out this nice overview❗️ #NephJC
🖼️ by Anvitha Rangan

Great American Society of Onconephrology e-seminar with Sandra Herrmann MD, FASN Shruti Gupta Andreas Kronbichler Rimda ERA - European Renal Association

It was fun to guest edit this important issue on Liver Kidney Connection with Juan Carlos Q Velez Ochsner Nephrology and Geetha Maddukuri SLU Nephrons

Thanks for the support Charuhas V Thakar
National Kidney Foundation
AKDH
UC Kidney
UC College of Medicine

The link between the histology of kidney transplant rejection and the types of infiltrating immune cells is not well charted. This study found the estimated immune cell composition of kidney transplants is ill related to Banff-defined rejection categories bit.ly/JASN0350

Apheresis trends in #kidney #transplantation poster at World Congress of Nephrology by UVA Nephrology team!
Jeanne Kamal Tushar Chopra

Despite an abundance of evidence, there is no consensus about how APOL1 injures kidney cells, the range of cell types affected, and the reason for different clinical phenotypes. This Perspective examines potential mechanisms of APOL1 kidney disease bit.ly/JASN0368

This meta-analysis examined the effectiveness and safety of #tirzepatide in treating overweight and obesity compared with other weight loss drugs and GLP-1 receptor agonists.
onlinelibrary.wiley.com/doi/epdf/10.10…

As Swapnil Hiremath @[email protected] points out, our task at implementation is going to become even more critical after FLOW

We need to reimagine, develop & refine a new framework that addresses urgency of optimising GDMT in ppl at high cardio-renal risk

Full text in Circulation ahajournals.org/doi/10.1161/CI…

About the powerful and pleitropic effect of glucosuria World Congress of Nephrology #ISNWCN

How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD?

-RASi
-SGLT2i
-ns-MRA
-GLP-1RA

Muthu Vaduganathan Katherine Tuttle & I outline what an 'accelerated, risk-based approach' might look like

Circulation ahajournals.org/doi/10.1161/CI…

REVIEW
Controversies regarding albumin therapy in cirrhosis
#JonelTrebicka Guadalupe GarciaTsao
#LiverTwitter
tinyurl.com/2j2burcu

Jacob way to go Jake Nysather DO UC Kidney UC College of Medicine
University of Cincinnati

Amit Govil, MD
Robert Blaser
KatieOverV
Brendan Bowman
RPA-Nephrology

Science behind the Study: CAR T-Cell Therapy for Glioblastoma nej.md/49yGoKf

#Neurology